These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 10077649)
21. Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor. Muraoka K; Ishii E; Ihara K; Imayoshi M; Miyazaki S; Hara T; Hamasaki Y Pediatr Transplant; 2005 Feb; 9(1):101-3. PubMed ID: 15667621 [TBL] [Abstract][Full Text] [Related]
22. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Ballmaier M; Germeshausen M; Krukemeier S; Welte K Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278 [TBL] [Abstract][Full Text] [Related]
23. Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia. Shah A; Kumar C; Shanmukhaiah C; Rajendran A; Mudaliar S; Idicula-Thomas S; Vundinti BR Ann Hematol; 2023 Oct; 102(10):2683-2693. PubMed ID: 37438490 [TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim. Pecci A; Ragab I; Bozzi V; De Rocco D; Barozzi S; Giangregorio T; Ali H; Melazzini F; Sallam M; Alfano C; Pastore A; Balduini CL; Savoia A EMBO Mol Med; 2018 Jan; 10(1):63-75. PubMed ID: 29191945 [TBL] [Abstract][Full Text] [Related]
26. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Savoia A; Dufour C; Locatelli F; Noris P; Ambaglio C; Rosti V; Zecca M; Ferrari S; di Bari F; Corcione A; Di Stazio M; Seri M; Balduini CL Haematologica; 2007 Sep; 92(9):1186-93. PubMed ID: 17666371 [TBL] [Abstract][Full Text] [Related]
27. Congenital amegakaryocytic thrombocytopenia with multiple physical anomalies in a female neonate. Saqlain N; Ahmed N; Qamar U J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S253-5. PubMed ID: 25518793 [TBL] [Abstract][Full Text] [Related]
28. F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents. Fox NE; Lim J; Chen R; Geddis AE Exp Hematol; 2010 May; 38(5):384-91. PubMed ID: 20188141 [TBL] [Abstract][Full Text] [Related]
32. [Congenital amegakaryocytic thrombocytopenia in a 12 year old boy with no signs of pancytopenia: molecular analysis]. Bastida Eizaguirre M; Pereda Vicandi A; Pujana Zaldegui I An Pediatr (Barc); 2008 Apr; 68(4):353-6. PubMed ID: 18394379 [TBL] [Abstract][Full Text] [Related]
33. Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations. Steinberg O; Gilad G; Dgany O; Krasnov T; Zoldan M; Laor R; Kapelushnik J; Gabriel H; Churi C; Stein J; Yaniv I; Tamary H J Pediatr Hematol Oncol; 2007 Dec; 29(12):822-5. PubMed ID: 18090929 [TBL] [Abstract][Full Text] [Related]
35. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life. Stoddart MT; Connor P; Germeshausen M; Ballmaier M; Steward CG Pediatr Blood Cancer; 2013 Sep; 60(9):E94-6. PubMed ID: 23625800 [TBL] [Abstract][Full Text] [Related]
36. Case Report: Clinical Variation in Children With Thrombopoietin Receptor (C-MPL) Mutations: Report of 2 Cases. Lo C; Alvarez E; Ohgami RS; Jeng M J Pediatr Hematol Oncol; 2018 Jan; 40(1):67-70. PubMed ID: 28859041 [TBL] [Abstract][Full Text] [Related]
37. Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl). Tonelli R; Strippoli P; Grossi A; Savoia A; Iolascon A; Savino M; Teriaca MS; Servedio V; Morfini M; Zelante L; Borgna-Pignatti C; Rosito P; Pession A; Paolucci G; Bagnara GP Thromb Haemost; 2000 Jun; 83(6):931-6. PubMed ID: 10896251 [TBL] [Abstract][Full Text] [Related]
38. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation. Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212 [TBL] [Abstract][Full Text] [Related]
39. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Geddis AE Hematol Oncol Clin North Am; 2009 Apr; 23(2):321-31. PubMed ID: 19327586 [TBL] [Abstract][Full Text] [Related]
40. Congenital amegakaryocytic thrombocytopenia (CAMT): a case report with review of literature. Desai SR; Ranade SR Indian J Pathol Microbiol; 2007 Jul; 50(3):659-60. PubMed ID: 17883175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]